[ Price : $8.95]
FDA accepts an Actelion NDA for Opsumit (macitentan), indicated for treating patients with pulmonary arterial hypertension.[ Price : $8.95]
Bayer HealthCare submits an NDA for radium Ra 223 dichloride, an investigational compound for treating castration-resistant prosta...[ Price : $8.95]
FDA denies a Jazz Pharmaceutical citizen petition that asked the agency to not accept any ANDA referencing its Xyrem that did not ...[ Price : $8.95]
FDA posts a long-awaited draft guidance on clinical trial enrichment strategies that can be used in studies to support effectivene...[ Price : $8.95]
FDA clears an Insulet Corp. 510(k) for the OmniPod Insulin Management System.[ Price : $8.95]
Federal Register Notice: FDAs Pulmonary-Allergy Drugs Advisory Committee will meet 3/7/13 to discuss a GlaxoSmithKline NDA for the...[ Price : $8.95]
Yale University of Medicine researchers develop a new screening approach to evaluate cancer drugs in combination with other drugs ...[ Price : $8.95]
The Federal Circuit Court of Appeals rules that a substance patent protecting AstraZenecas Crestor is valid and enforceable.